Preclinical Oncology Models Market - Recent Innovations and Upcoming Trends Analysis
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Preclinical Oncology Models Market- by Product (Patient-Derived Xenograft Models (PDX), Cell Line Derived Xenograft Models, Syngeneic Models, Genetically engineered mouse models (GEMMs), Orthotopic Models, Custom Xenograft and Syngeneic Model and Others), Application (Neuroblastoma, Prostate Cancer, Pancreatic Cancer, Breast Cancer, Colorectal Cancer, Bladder Cancer, Fibrosarcoma, Kidney Cancer, Liver Cancer, Lung Cancer, Lymphoma, Skin Cancer and Others), Trends, Industry Competition Analysis, Revenue and Forecast To 2024- 2030."Get a free sample copy of the report: https://www.insightaceanalytic.com/request-sample/1093
InsightAce Analytic's most recent study projects that the global market for preclinical oncology models will be worth US$1.02 billion by 2021. With a prediction period of 2024-2030 and a compound annual growth rate of 10.6%, it is anticipated to reach US$2.46 billion by 2030. Researchers need to use preclinical oncology models to predict the clinical efficacy of novel anticancer medications. The growing need for cancer immunotherapy has brought about many preclinical and translational challenges.
Preclinical models are essential for precisely screening anticancer medications with strong clinical associations. Growth in immuno-oncology, rising targeted and novel cancer therapies, increased oncology-related R&D activities, high demand for dependable preclinical oncology models, such as humanized and syngeneic tumour models, and the increasing need to lower translational failures in clinical trials are expected to fuel the market growth. Preclinical oncology model sales are also aided by the need for combination medications to be logically designed and the early discovery of predictive biomarkers.
Preclinical cancer models are becoming increasingly popular because of the need for logical combination therapy design, early identification of predictive biomarkers, and utilizing the phenotypic elements of models. The advent of immuno-oncology treatments such as immune checkpoint modulators, T-cell therapy, bispecific antibodies, and customized cancer vaccines requires creating innovative preclinical and translational service solutions.
Several competitors offer services in both domestic and international markets, resulting in a fragmented market for preclinical oncology models. Due to the necessity of preclinical oncology models, increased funding for cancer research, and a high demand for cancer immunotherapies, North America is expected to contribute to the market for preclinical oncology models. Furthermore, a notable growth in the Asia Pacific Preclinical Oncology Models market is anticipated.
The main factors propelling the regional market expansion are the advancement of cancer therapeutic and diagnostic technologies, the growing need for targeted medications, and the escalating R&D efforts in oncology clinical trials by industry players. Aragen Bioscience, vivoPharm Pty. Ltd., Bioduro, Crown Bioscience Inc., Charles River, Champion Oncology, Inc., Envigo, GenOway S.A., Hera BioLabs, MI Bioresearch Inc., Pharmatest Services, Taconic Biosciences, Inc., and The Jackson Laboratory are some of the primary industry participants in the Preclinical Oncology Models market.
Recent collaborations and agreements in the market:
• In December 2021, the Crown Bioscience facility in the United Kingdom grew. Crown Bioscience is a top contract research organization (CRO) for preclinical and translational drug development services. This expansion provides more imaging options to help observe and comprehend the course of the tumor and its response to potential treatments. The new imaging platform enables the execution of state-of-the-art preclinical research, providing advanced insights on possible medication candidates before clinical trials.
• In February 2021, Kibur Medical and Charles River Laboratories International, Inc. collaborated to give in vivo preclinical oncology studies exclusive access to their implantable microdevice (IMD).
Curious about this latest version of the report? Obtain Report Details @ https://www.insightaceanalytic.com/enquiry-before-buying/1093
Market Segments
Global Preclinical Oncology Models Market, by Product, 2022-2030 (Value US$ Mn)
• Patient-Derived Xenograft Models (PDX)
• Cell Line Derived Xenograft Models
• Syngeneic Models
• Genetically engineered mouse models (GEMMs)
• Orthotopic Models
• Custom Xenograft and Syngeneic Model
• Others
Global Preclinical Oncology Models Market, by Application, 2022-2030 (Value US$ Mn)
• Neuroblastoma
• Prostate Cancer
• Pancreatic Cancer
• Breast Cancer
• Colorectal Cancer
• Bladder Cancer
• Fibrosarcoma
• Kidney Cancer
• Liver Cancer
• Lung Cancer
• Lymphoma
• Skin Cancer
• Others
Global Preclinical Oncology Models Market, by Region, 2022-2030 (Value US$ Mn)
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa
North America Preclinical Oncology Models Market, by Country, 2022-2030 (Value US$ Mn)
• U.S.
• Canada
Europe Preclinical Oncology Models Market, by Country, 2022-2030 (Value US$ Mn)
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe
Asia Pacific Preclinical Oncology Models Market, by Country, 2022-2030 (Value US$ Mn)
• India
• China
• Japan
• South Korea
• Australia & New Zealand
Latin America Preclinical Oncology Models Market, by Country, 2022-2030 (Value US$ Mn)
• Brazil
• Mexico
• Rest of Latin America
Middle East & Africa Preclinical Oncology Models Market, by Country, 2022-2030 (Value US$ Mn)
• GCC Countries
• South Africa
• Rest of Middle East & Africa
Why should buy this report:
To receive a comprehensive analysis of the prospects for the global Preclinical Oncology Models market
To receive an industry overview and future trends of the Preclinical Oncology Models market
To analyze the Preclinical Oncology Models market drivers and challenges
To get information on the Preclinical Oncology Models market value (US$ Mn) forecast to 2030
Significant investments, mergers & acquisitions in the Preclinical Oncology Models market industry
For More Information @ https://www.insightaceanalytic.com/customisation/1093
Contact Us:
InsightAce Analytic Pvt. Ltd.
Tel.: +1 718 593 4405
Email: info@insightaceanalytic.com
Site Visit: www.insightaceanalytic.com
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions.
Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses.
We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products.
Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Preclinical Oncology Models Market - Recent Innovations and Upcoming Trends Analysis here
News-ID: 3452590 • Views: …
More Releases from InsightAce Analytic Pvt.Ltd
Biosimilar Monoclonal Antibodies Market Latest Report with Forecast to 2031
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Biosimilar Monoclonal Antibodies Market- by Product (Infliximab, Trastuzumab, Rituximab, Adalimumab, Bevacizumab, Cetuximab, Ranibizumab, Denosumab, Eculizumab and Other Pipeline Products), Indication (Oncology, Inflammatory & Autoimmune Disorders, Chronic Diseases, Blood Disorders and Other Indication), Trends, Industry Competition Analysis, Revenue and Forecast To 2024- 2030."
Get a free sample copy of the report: https://www.insightaceanalytic.com/request-sample/1218
InsightAce Analytic's most recent study…
Cell and Gene Therapy Supply Chain/Logistics Market Reviews Analysis Report 2024
InsightAce Analytic Pvt. Ltd. announces the release of market assessment report on "Global Cell and Gene Therapy Supply Chain/Logistics Market (By Application area (Donor eligibility assessment, Sample collection, Manufacturing, Logistics, Patient verification and treatment follow-up), By Type of software solution (Cell orchestration platform, Enterprise manufacturing system, Inventory management system, Laboratory information management system, Logistics management system, Patient management system, Quality management system,
Tracking and tracing system), By Mode of Deployment…
2D Materials Market 2024-2031 | Exclusive Study Report
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global 2D Materials Market Size, Share & Trends Analysis Report By Material (Graphene, Black Phosphorous, Transition Metal Dichalcogenides, Mxenes, Hexagonal Boron Nitride), And End Users (Composite And Coating, Energy Storage Devices, Electronics, Semiconductors, Pharmaceuticals, Automobiles )- Market Outlook And Industry Analysis 2031"
The 2D Materials market will reach over USD 36.27 billion by 2024-2031, exhibiting…
AI in Respiratory Diseases Market Revenue Share Study Analysis Report
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global AI in Respiratory Diseases Market- (By Indication (Chronic Obstructive Pulmonary Disease, Interstitial Lung Disease, Pulmonary Infection), By Imaging Type (MRI, CT Scan, ePRO), By End-use (Hospital, Diagnostic Centers, Ambulatory Surgical centers, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest research by InsightAce Analytic, the Global AI in Respiratory Diseases Market…
More Releases for Model
Model Making Dubai
Architectural model making is an integral part of the design process as it helps architects and designers explore project potential and visualize the outcome.
Models are also used to communicate the project vision to other relevant parties involved in the process. Thus, making accurate and effective models is essential to get projects off the ground.
If you want to enhance your models this year, read on to learn how to make the…
How Drizly Works: Business Model & Revenue Model
‘Slow and steady wins the race.’
Such is the case with the world’s leading alcohol marketplace, Drizly which carved a unique, step-by-step growth strategy for itself and eventually, succeeded in transforming the way alcohol is bought and sold across various continents. Co-founded in 2012 by Cory Rellas and Nick Rellas, the Boston-based start-up which was one of the first few on-demand liquor delivery apps to make its way into the market,…
Animal Model Market trends, Animal Model Market growth, Animal Model Market size …
Key Findings of Animal Model Market
Developing Regions to Overpower Developed Ones With Regard to Demand
The Asian territory is on the verge of evolving as the next big destination for animal models. This growth can be attributed to various factors such as American and European pharmaceutical companies diversifying their research activities to curtail extra expenses and save costs. Although U.S and Europe have retained their legacy in the global market, their…
Chinese Local Model Company , RJ Models is Becoming World-leading Model Maker
RJ Models(https://www.rjmodels.com.hk/) is a world-leading Chinese architectural model making company and has cooperated with many world-famous architects and companies many times around the world, such as Norman Forster, KPF and SOM.
“For over twenty years, RJ Models particularly enjoyed working collaboratively with the clients around China”, said Ray Cheung, the founder, and leader of RJ Models.
RJ Models has hundreds of completed and ongoing model projects in China(https://www.rjmodels.com.hk/architectural-model-makers-in-China), including large numbers of…
Cloud Computing in Healthcare Market By Deployment Model (Public- cloud deployme …
Industry Outlook and Trend Analysis
The Cloud Computing in Healthcare Market was worth USD 3.05 billion in 2014 and is expected to reach approximately USD 16.25 billion by 2023, while registering itself at a compound annual growth rate (CAGR) of 20.43% during the forecast period. Cloud computing, commonly alluded to as 'the cloud', is a technique to access and store the information and projects over the internet. The cloud computing is…
Global Toy Model Market 2017 Model Blackhawk, Thunder Tiger, Disney, Vantex
The latest report Toy Model by QY Research added to it's database and brings to light the comprehensive study and factual information of global market. The report also provides the global market segmentation based on applications, end-users, technology, and geography. The Toy Model research report offers a comprehensive assessment of the Toy Model market and consists of historical data, scope, significant approaches and statistical data of the global market. Besides…